A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

This study aims to assess Symbol Digit Modalities Test (SDMT) changes in patients with stable relapsing-remitting MS (RRMS ... (EDSS)), volumetric MRI measures (total lesion volume (TLV), corrected ...

There are relapsing-remitting and progressive types of ... People who are at high risk of developing MS are found to have lesions on the brain that can be detected through magnetic resonance ...

Importantly, the reduction in staph also was accompanied by a reduction in inflammatory signals, including interferon-driven gene expression, in the lesions. “In addition to decreasing the ...

The body’s immune system mistakenly attacks a substance called myelin that surrounds and protects the nerves in the brain and spinal ... a diagnosis of relapsing remitting MS (RRMS).

It is important to realize that both disease activity and current therapies can influence brain volume. Brain volume can transiently increase with the inflammation and edema that are associated ...

This mechanism of action provides the rationale for use in relapsing–remitting multiple ... multiple sclerotic lesions or plaques disseminated throughout the brain and spinal cord, and ...